{"id":1038254,"date":"2012-03-17T00:43:32","date_gmt":"2012-03-17T00:43:32","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/uncategorized\/american-oriental-bioengineering-inc-announces-delay-in-filing-of-its-annual-report-on-form-10-k-for-2011.php"},"modified":"2024-08-17T16:15:22","modified_gmt":"2024-08-17T20:15:22","slug":"american-oriental-bioengineering-inc-announces-delay-in-filing-of-its-annual-report-on-form-10-k-for-2011","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/bioengineering\/american-oriental-bioengineering-inc-announces-delay-in-filing-of-its-annual-report-on-form-10-k-for-2011.php","title":{"rendered":"American Oriental Bioengineering Inc. Announces Delay in Filing of its Annual Report on Form 10-K for 2011"},"content":{"rendered":"<p><p>      NEWARK,N.J., March 16, 2012 \/PRNewswire-Asia-FirstCall\/      -- American Oriental Bioengineering, Inc. (NYSE:       AOB -       News) (the \"Company\"), today announced that its Annual      Report on Form 10-K for the fiscal year ended December 31,      2011, which was due on March 15, 2012, will not be timely      filed. During the performance of Ernst & Young Hua      Ming's audit for the 2011 fiscal year they noted certain      inconsistencies. As a result, management and the Audit      Committee of the Board of Directors have agreed that the      Audit Committee would immediately commence an independent      investigation into the matters identified. Although the      length of the investigation is uncertain at this time, the      Company will endeavor to file the Form 10-K as soon as      possible upon the completion of the investigation.    <\/p>\n<p>      About American Oriental Bioengineering, Inc.    <\/p>\n<p>      American Oriental Bioengineering, Inc. is a pharmaceutical      company dedicated to improving health through the      development, manufacture and commercialization of a broad      range of prescription and over the counter products.    <\/p>\n<p>      Safe Harbor Statement    <\/p>\n<p>      Statements made in this press release are forward-looking and      are made pursuant to the safe harbor provisions of the      Securities Litigation Reform Act of 1995. Such      statements involve risks and uncertainties that may cause      actual results to differ materially from those set forth in      these statements. The economic, competitive,      governmental, technological and other factors identified in      the Company's filings with the Securities and Exchange      Commission, may cause actual results or events to differ      materially from those described in the forward looking      statements in this press release. The Company      undertakes no obligation to publicly update or revise any      forward-looking statements, whether because of new      information, future events, or otherwise.    <\/p>\n<p>      Contact:    <\/p>\n<p>      Hong Zhu      646-367-1765    <\/p>\n<\/p>\n<p>Here is the original post:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/american-oriental-bioengineering-inc-announces-120000094.html\" title=\"American Oriental Bioengineering Inc. Announces Delay in Filing of its Annual Report on Form 10-K for 2011\" rel=\"noopener\">American Oriental Bioengineering Inc. Announces Delay in Filing of its Annual Report on Form 10-K for 2011<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> NEWARK,N.J., March 16, 2012 \/PRNewswire-Asia-FirstCall\/ -- American Oriental Bioengineering, Inc. (NYSE: AOB - News) (the \"Company\"), today announced that its Annual Report on Form 10-K for the fiscal year ended December 31, 2011, which was due on March 15, 2012, will not be timely filed. During the performance of Ernst &#038; Young Hua Ming's audit for the 2011 fiscal year they noted certain inconsistencies.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/bioengineering\/american-oriental-bioengineering-inc-announces-delay-in-filing-of-its-annual-report-on-form-10-k-for-2011.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246861],"tags":[],"class_list":["post-1038254","post","type-post","status-publish","format-standard","hentry","category-bioengineering"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1038254"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1038254"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1038254\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1038254"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1038254"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1038254"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}